FOCAL

New Driver Training Developed at Cincinnati Children's Keeps Teens with ADHD Safer Behind the Wheel

Retrieved on: 
Thursday, December 1, 2022
The New England Journal of Medicine, Video, Doctor of Philosophy, Injury, FOCAL, Attention, Cincinnati Children's Hospital Medical Center, Multimedia, ADHD, Risk, Behavioral medicine, Fatality, Crash, Parent, Attention deficit hyperactivity disorder predominantly inattentive, Ageing, Hope, Division, Safety, Sound, Road, Tunnel, Mobile phone, Toy

CINCINNATI, Dec. 1, 2022 /PRNewswire/ -- Roadways can be a dangerous place for teen drivers, even more so for those diagnosed with attention-deficit/hyperactivity disorder (ADHD). This is because those with ADHD may have difficulty sustaining visual attention to the roadway, especially when distracted.

Key Points: 
  • This is because those with ADHD may have difficulty sustaining visual attention to the roadway, especially when distracted.
  • -- Jeff Epstein, PhD
    Now, an ADHD driver's training program developed at Cincinnati Children's reports success at reducing the frequency of long, distracted glances away from the road that often occur among youth with ADHD.
  • The study details outcomes of the FOCAL+ training program, which expands upon a desktop-based software platform called FOcused Concentration and Attention Learning (FOCAL).
  • As a result of the success of the study, Cincinnati Children's is now offering this training to teens with ADHD.

CLS Americas & Focalyx Present Integrated Fusion-Guided Focal Laser Ablation Solution at FOCAL 2022 Conference

Retrieved on: 
Friday, September 23, 2022
Workflow, Safety, Prostate, 3D, CLS, Brain, Urology, Erectile dysfunction, Company, Learning curve, MRI, Technology, Anticonvulsant, Patient, Urinary incontinence, Clinical trial, FOCAL, III, Quality of life, Nasdaq, Diagnosis, Magnetic resonance imaging, Conference, Prostate cancer, GLOBE, Man, University college, Laser ablation, Experience, Medical imaging, EU

Compared to other focal therapies, focal laser ablation therapy has demonstrated higher levels of precision and accuracy with lower risk of side effects, such as erectile dysfunction and urinary incontinence.

Key Points: 
  • Compared to other focal therapies, focal laser ablation therapy has demonstrated higher levels of precision and accuracy with lower risk of side effects, such as erectile dysfunction and urinary incontinence.
  • CLS Americas is excited to demonstrate our new office-based, fusion-guided, focal Laser Ablation solution to FOCAL 2022 attendees in conjunction Focalyx Technologies and Urological Research Network, stated Michael Magnani, president of CLS Americas.
  • CLS History & Experience Image-Guided, Focal Laser Ablation of Prostate Tumors
    CLSs TRANBERG Thermal Therapy System has been used in hundreds of tumor laser ablation procedures in patients with localized prostate cancer in the US and EU using an in-bore, MRI-guided procedure.
  • CLS is leveraging its in-bore MR experience and applying it to MR/US, fusion-guided transperineal procedures and technology to perform focal laser ablation of prostate tumors with the TRANBERG Thermal Therapy System.

Avenda Health Raises $10M in Series B, Innovating Detection and Treatment for Prostate Cancer Care

Retrieved on: 
Thursday, August 25, 2022
Neoplasm, Engineering, American Urological Association, CEO, Technology, FOCAL, 3D, Disease, Plug, Physician, Health, Quality of life, Deep learning, FDA, MRI, Prostate cancer, Men's Health, AI, Patient, Medical imaging, Urology

Avenda Health has introduced technology that is innovating the men's health industry to improve treatment and cancer mapping for prostate cancer care.

Key Points: 
  • Avenda Health has introduced technology that is innovating the men's health industry to improve treatment and cancer mapping for prostate cancer care.
  • The Avenda Health FocalPoint System powered by iQuest reimagines laser ablation with a system to treat prostate cancer in-office under ultrasound guidance while preserving quality of life.
  • Our technology is solving key issues in men's health and we look forward to creating real change in prostate cancer care," said Dr. Shyam Natarajan, co-founder and CEO of Avenda Health.
  • Avenda Health is creating a more personalized future of prostate cancer care.Using deep learning, Avenda Health software maps a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions.Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.